52 Week Range
As of on the Stock Exchange of Thailand (Bangkok) ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Thonburi Healthcare Group Clarifies On Pfizer Vaccine Import
Thonburi Healthcare Group Posts Qtrly Loss Attributable Of 215 Mln Baht
Thonburi Healthcare Group Posts FY Profit Attributable 62.4 MLN Baht
Thonburi Healthcare Group Public Company Limited (THG) is a Thailand-based company. The Company medical services business, healthcare solution provider and other business. THG’s core business is the medical treatment business with five sub-categories: domestic medical services, overseas medical services, specialized hospital and step-down care, hospital management services, and specialized medical services centers. The healthcare solution Provider business includes senior care and senior living; home healthcare; and distribution of medical supplies, devices and equipment. The other businesses includes software development for hospital management, and project development relating to health and medical services.
34/1 Itsaraphap Rd, Ban Chang Lor
Chairman of the Board
Chairman of the Executive Board, Chief Executive Officer, Vice Chairman of the Board, Chief Hospital Business International, Chief Business Service/Support Officer
Chief Financial Officer
Acting Chief Operating Officer - Group 2, Chief PPP Business
Chief Hospital Business Domestic 2, Executive Director
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
The chair of Thailand's Thonburi Healthcare Group (THG) said on Wednesday that a deal to import 20 million doses of the Pfizer-BioNTech COVID-19 vaccine was unlikely to happen, despite his earlier claims that a deal was close.
Thailand’s Thonburi Healthcare Group Pcl (THG) doubled down on its outspoken chairman's claim to be buying Pfizer-BioNTech vaccines on Friday, helping its share price rise despite denials by both drugmakers.
Pfizer and Germany's BioNTech denied on Thursday that they were in talks with Thailand's Thonburi Healthcare Group Pcl for a deal to import 20 million doses of the coronavirus vaccine to the Southeast Asian country.
Germany BioNTech said on Thursday it was not in talks with Thai Thonburi Healthcare Group Pcl about a sale of its vaccines.
Thai private hospital operator Thonburi Healthcare Group Pcl on Thursday said it will sign an agreement to procure 20 million doses of the Pfizer-BioNTech vaccines.
Thailand's state drugmaker on Wednesday said it had initiated a defamation suit against the prominent chairman of a private hospital operator over his criticism of its procurement of Moderna COVID-19 vaccines.
A hospital in Thailand taking reservations this week for the Moderna coronavirus vaccine was sold out in minutes - after offering shots via e-commerce platform Shopee.
Thai tourism operators and hospitals said on Wednesday they planned to lodge a protest against a government move to curb private imports of COVID-19 vaccines, marking an apparent turnaround in policy by authorities.
Thailand's plan to produce the AstraZeneca coronavirus vaccine locally is on track to be ready to begin mass inoculations in June, with a capacity to make up to 18 million doses per month, a senior official said on Friday.
Two private hospitals in Thailand have ordered millions of doses of coronavirus vaccines ahead of regulatory approval, adding to government orders of vaccines as the Southeast Asian country tackles a second wave of the virus.
Thailand is to ease its novel coronavirus procedures to allow more patients from abroad to get treatment from next month, a top health official said on Thursday, after appeals from hospitals eager to treat their overseas patients.
* FY PROFIT ATTRIBUTABLE 462.4 MILLION BAHT VERSUS 347.6 MILLION BAHT
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.